Imaging for the Detection of Locoregional Recurrences in Biochemical Progression After Radical Prostatectomy-A Systematic Review.


Journal

European urology focus
ISSN: 2405-4569
Titre abrégé: Eur Urol Focus
Pays: Netherlands
ID NLM: 101665661

Informations de publication

Date de publication:
07 2019
Historique:
received: 12 06 2017
revised: 13 10 2017
accepted: 02 11 2017
pubmed: 15 11 2017
medline: 23 10 2020
entrez: 15 11 2017
Statut: ppublish

Résumé

Local and regional recurrence after radical prostatectomy (RP) can be treated using salvage radiotherapy (SRT). If the recurrence can be delineated on diagnostic imaging, this could allow for increasingly individualized SRT. This systematic review aimed at evaluating the evidence regarding the usefulness of positron emission tomography (PET) and magnetic resonance imaging (MRI) in identifying local and regional recurrences, with the aim to further individualize the SRT treatment. A systematic PubMed/Medline search was conducted in December 2015. Studies included were imaging studies of post-RP patients focusing on local and/or regional recurrence where sensitivity and specificity of MRI or PET were the primary end points. Only studies using biopsy, other histological analysis, and/or treatment follow-up as reference standard were included. Quality Assessment of Diagnostic Accuracy Studies-2 was used to score the study quality. Twenty-five articles were deemed of sufficient quality and included in the review. [ Both MRI and PET have adequate sensitivity and specificity for the detection of prostate cancer recurrences post-RP. Multiparametric MRI, using diffusion-weighted and/or DCE imaging, and the choline-labeled tracers showed high pooled sensitivity and specificity, although their ranges were broad. After reviewing imaging studies of recurrent prostate cancer after prostatectomy, we concluded that choline positron emission tomography and diffusion-weighted magnetic resonance imaging can be proposed as the current standard, with high sensitivity and specificity.

Identifiants

pubmed: 29133278
pii: S2405-4569(17)30257-2
doi: 10.1016/j.euf.2017.11.001
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

550-560

Informations de copyright

Copyright © 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Kristina Sandgren (K)

Department of Radiation Sciences, Umeå University, Umeå, Sweden. Electronic address: kristina.sandgren@umu.se.

Philippe Westerlinck (P)

Department of Radiation Oncology, Iridium Cancer Network, Wilrijk (Antwerp), Belgium.

Joakim H Jonsson (JH)

Department of Radiation Sciences, Umeå University, Umeå, Sweden.

Lennart Blomqvist (L)

Department of Radiation Sciences, Umeå University, Umeå, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Camilla Thellenberg Karlsson (C)

Department of Radiation Sciences, Umeå University, Umeå, Sweden.

Tufve Nyholm (T)

Department of Radiation Sciences, Umeå University, Umeå, Sweden; Department of Immunology, Genetics, and Pathology, Medical Radiation Science, Uppsala University, Uppsala, Sweden.

Piet Dirix (P)

Department of Radiation Oncology, Iridium Cancer Network, Wilrijk (Antwerp), Belgium; Department of Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO), Center for Oncological Research (CORE), Edegem (Antwerp), Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH